Bank of America Projects Fed Rate Cuts Unlikely Until Second Half of 2027 CBS News Report Global Leaders Closely Monitor Potential TrumpXi Summit Amid Trade Tensions Kevin Warsh to Succeed Jerome Powell as Fed Chair Vows ReformOriented Approach EasyJet Faces Wider FirstHalf Losses as Iran Conflict Drives Fuel Costs and Dampens Summer Demand Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement The Power of Acting As If Financial Lessons from Theatre and Music Stars PFG Q1 2026 Earnings EPS Beat Amid Modest Share Decline AUBN Q1 2026 Earnings Solid EPS of 063 Amid Stable Regional Bank Operations KMDA Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Dyadic International Inc DYAI Q1 2026 Earnings Wider Loss as RD Investment Accelerates Stock Rises on Pipeline Hope German American Bancorp Inc GABC Q1 2026 Earnings EPS Misses Estimates Stock Declines on Headwinds Freedom Holding Corp FRHC Q1 2026 Earnings Solid EPS Reported Amid Quiet Disclosure Shares Slip Pearson PSO Edges Lower as Stock Tests Key Support Zone First Seacoast Bancorp FSEA Edges Higher as Stock Holds Above Key Support Marathon Petroleum MPC Pulls Back Amid Broader Energy Weakness Gartner IT Edges Higher in Steady Trading Testing Key Resistance Zone SailPoint Inc SAIL Shows Resilience Trading Near Resistance After 393 Gain Global X Social Media ETF SOCL Capturing Catalytic Upside From Baidus Historic Shareholder Return Policy Shift Sana Biotechnology SANA Stock Should You Consider Buying Q4 2025 Profit Disappoints VWAVW VisionWave management highlights new AI product launches as core strategic priority for the coming fiscal year Is Rezolute RZLT stock stabilizing after decline Rezolute posts 154 EPS miss as Q1 loss widens How sustainable is Astera Labs ALAB profit margins 408 20260503 The RD spending story behind The RealReal REAL innovation The RealReal Beats EPS Forecast Loss Narrows Bitcoin Surges Past 77000 as Iran Deal Optimism and Nasdaq Crypto Options Plan Fuel Rally GALT Q1 2026 Earnings EPS Misses Estimates as Clinical Development Continues Columbus Circle Capital Corp II Warrants CMIIW Remain Flat at 034 as Investors Await Catalyst